Publications by authors named "Julia D Suerth"

Claim this Profile
C
Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.
Julia D Suerth, Michael A Morgan, Stephan Kloess, Dirk Heckl, Christine Neudörfl

J Mol Med (Berl)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells.
Yvonne Baron, Johanna Sens, Lucas Lange, Larissa Nassauer, Denise Klatt, Julia D Suerth

Mol Ther Nucleic Acids· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
Juwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, Dirk Hoffmann, Marcel Maluski

Mol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes.
Verena Labenski, Julia D Suerth, Elke Barczak, Dirk Heckl, Camille Levy

Biomaterials· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.
Julia D Suerth, Michael A Morgan, Stephan Kloess, Dirk Heckl, Christine Neudörfl

J Mol Med (Berl)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RETRACTED: Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome.
Emanuele G. Coci, Tobias Maetzig, Daniela Zychlinski, Michael Rothe, Julia D. Suerth

Curr Gene Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages and applications of CAR-expressing natural killer cells.
Wolfgang Glienke, Ruth Esser, Christoph Priesner, Julia D Suerth, Axel Schambach

Front Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.
Julia D Suerth, Verena Labenski, Axel Schambach

Viruses· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.
Johannes Kuehle, Soeren Turan, Tobias Cantz, Dirk Hoffmann, Julia D Suerth

Mol Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells.
Arianna Moiani, Julia Debora Suerth, Francesco Gandolfi, Ermanno Rizzi, Marco Severgnini

Genes (Basel)· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
Arianna Moiani, Annarita Miccio, Ermanno Rizzi, Marco Severgnini, Danilo Pellin, Julia Debora Suerth

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.
Martijn H Brugman, Julia D Suerth, Michael Rothe, Sebastian Suerbaum, Axel Schambach

Hum Gene Ther Methods· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Kerstin B Kaufmann, Christian Brendel, Julia D Suerth, Uta Mueller-Kuller, Linping Chen-Wichmann

Mol Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic modification of lymphocytes by retrovirus-based vectors.
Julia D Suerth, Axel Schambach, Christopher Baum

Curr Opin Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
Julia D Suerth, Tobias Maetzig, Martijn H Brugman, Niels Heinz, Jens-Uwe Appelt

Mol Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-inactivating alpharetroviral vectors with a split-packaging design.
Julia D Suerth, Tobias Maetzig, Melanie Galla, Christopher Baum, Axel Schambach

J Virol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis